FONAR Corporation

NASDAQ:FONR

Medical - Devices

Healthcare
$19.09 +0.00%

+$0.00 today

Market cap
$117.76M
Beta
0.95
P/E (TTM)
17.6
EPS (TTM)
$1.08
52W Low $13.62High $19.16

Volume 0.00M

Average 0.08M

FONR Net Income

Bottom-line profit, the starting point for calculating cash from operations.

FONAR CorporationNASDAQ: FONR

Net Income · Q3 FY2026 · quarter ended Mar 2026

Net income declines year over year

Q3 FY2026 net income of $2.33M fell 7.1% year over year, ahead of the -11.1% change in trailing-twelve-month net income. Sequentially, it fell 21.0% from the prior quarter. Over 3 fiscal years it compounded at -14.8% a year.

Context

  • Net income amounted to 10.2% of revenue in FY2025, down 3.5 pp from a year earlier.
  • Net income increased in 1 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of -7.1% holds above the trailing-twelve-month pace of -11.1%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
$2.33M-21.0% QoQ
Last fiscal yearJun 2025
$10.67M-24.3% YoY
LTMMar 2026
$8.27M-11.1% YoY
Net Income past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-7.1%——
1 year-24.3%——
3-year CAGR-14.8%——
5-year CAGR——
10-year CAGR——

Net Income history

USD · from the cash flow

Latest · FY2025
10.67M USD
Year-over-year change
-24.3%
4-year CAGR
-6.0%

Net Income vs competitors

How FONR compares with its peers on the latest reported figures

  • Peers report in different currencies, so net income is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -11.1% is the 5th highest of 8, against a peer median of -7.9%.
  • Net income amounts to 7.8% of revenue for FONR, versus a peer median of 62.7%.
FONR Competitors
Net Income for FONR and competitors
Company Period LTM YoY 3-year CAGR% of revenue
ARTVArtiva Biotherapeutics, Inc.LTM Mar 2026$87.07M USD+21.4%+12.6%—
LUNGPulmonx CorporationLTM Mar 2026$53.21M USD-6.8%-2.9%60.1%
RCELAVITA Medical, Inc.LTM Mar 2026$45.34M USD-20.5%+22.1%62.7%
IFRXInflaRx N.V.LTM Mar 2026€41.2M EUR-7.9%+14.1%140477.1%
HYPRHyperfine, Inc.LTM Mar 2026$34.78M USD-13.7%-21.4%226.9%
VANIVivani Medical, Inc.LTM Mar 2026$27.09M USD+14.1%+24.2%—
APYXApyx Medical CorporationLTM Mar 2026$9.05M USD-55.1%-21.9%16.2%
FONRFONAR CorporationLTM Mar 2026$8.27M USD-11.1%-14.8%7.8%
Peer median (excluding FONR) —-7.9%+12.6%62.7%

Competitors are the stored peer set for FONR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Jun 2021
FY2022
Jun 2022
FY2023
Jun 2023
FY2024
Jun 2024
FY2025
Jun 2025
Net Income13.67M17.23M12.13M14.1M10.67M
Depreciation & Amortization5.54M8.54M8.8M4.6M4.7M
Deferred Income Tax3.53M3.09M2.98M2.8M823.66K
Stock-Based Compensation83.28K0000
Change in Working Capital(11.26M)(14.21M)(15.17M)(8.62M)(8.19M)
Accounts Receivables(11.91M)(5.56M)(8.12M)(11.62M)(8.98M)
Inventory(14.65K)(696.4K)(209.85K)(145.78K)(97.24K)
Accounts Payables(99.22K)(314.77K)19.69K276.67K(553.56K)
Other Working Capital762.59K(7.64M)(6.86M)2.87M1.44M
Other Non-Cash Items7.53M642.77K5.73M1.22M3.26M
Operating Cash Flow19.09M15.3M14.47M14.09M11.26M
Capital Expenditures(4.82M)(4.63M)(4.34M)(822.85K)(3.82M)
Acquisitions (Net)0(546K)000
Purchases of Investments(293)(149)(473)(103.3K)0
Sales of Investments00000
Other Investing Activities(163.71K)(87.88K)(119.57K)42.53K(9.72K)
Investing Cash Flow(4.82M)(5.18M)(4.34M)(850.74K)(3.8M)
Debt Repayment(40.34K)(37.24K)(36.62K)(44.9K)(113.94K)
Common Stock Issued00000
Common Stock Repurchased00(1.76M)(2.51M)(1.81M)
Dividends Paid00000
Other Financing Activities(6.57M)(5.82M)(5.78M)(5.63M)(5.55M)
Financing Cash Flow(6.61M)(5.86M)(7.57M)(8.18M)(7.47M)
Effect of Forex Changes00000
Net Change in Cash7.66M4.26M2.56M5.06M(7.56K)
Free Cash Flow14.27M10.67M10.13M13.27M7.45M

FONAR Corporation

NASDAQ:FONR

Intrinsic Alpha fair value

Locked

Current Price

$19.09

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.